English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Aim: To evaluate the effect of submucosal tramadol on VAS scores after septoplasty operations and patient satisfaction. Method: 100 patients between 18 and 60 years of age who were scheduled for elective septoplasty were enrolled in a double-blind randomized controlled study. The patients were randomly divided into 2 group, group T and Group P. In Group T, at the end of surgery following hemostasis, 2 mg/kg tramadol was applied as submucosal infiltration to both surgical site i.e. 2 ml (total 4 ml), by the surgeon. In Group P, at the end of surgery following hemostasis, 2 ml isotonic solution (total 4 ml) was applied as submucosal infiltration to both surgical sites by the surgeon. Post operative pain was evaluated using Visual analogue scale (VAS) scores at 1, 2, 4, 6, 12 and 24 hours (h) following surgery. There was no difference in additional analgesic consumption between two groups. Results: Post operative pain intensity was significantly lower in group T in comparison with group P during the first 24 hours after surgery (P < 0.001). Conclusion: Submucosal infiltration of tramadol in septoplasty patients can decrease post operative pain, analgesic consumption, and the time to recovery without significant side effects.

The Efficacy of Submucosal Tramadol in the Postoperative Treatment of Pain Following Septoplasty Operations